Methylprednisolone Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2020 - 2025

Report Code: HCR 41083 Report Format: PDF + Excel (Delivery in 48 Hrs)
Methylprednisolone Market size is forecast to reach $852.7 Million by 2025, growing at a CAGR of 3.21% during the forecast period 2020-2025. Methylprednisolone, sold under the brand name Depo-Medrol among others, is a corticosteroid medication and immunosuppressive drug used to suppress the immune system and decrease inflammation. Methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. Intravenous methylprednisolone (Solu-medrol) has been shown effective in the treatment of chemotherapy-induced nausea and vomiting.This medication is a corticosteroid hormone. Methylprednisolone is known to interact with drugs like indomethacin, carvedilol and enalapril, which in some cases turns out to provide side effects. Methylprednisolone can also be used with other medications in hormone disorders. Rapidly increasing chronic disorders among the growing geriatric population, increasing frequency of brain tumors and dermatological problems, rapid market developments by key market players and growing health awareness are driving the market growth in recent years. In addition, developments by market players like Oakrum Pharma are other factors driving the growth of the market. 

Report Coverage
The report: “Methylprednisolone Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Methylprednisolone Market.
 
By Product Type: Infusion Type, Oral Type
By Application: Medical, Research & Development
By Geography: North America, Europe, Asia-Pacific, Rest of the World (RoW)

Key Takeaways
  • North America dominated the Methylprednisolone Market in the year 2019, owing to the well-developed economy of the region, rising health care expenditure, increasing incidence of lifestyle-related diseases and increasing investments by key market players for better R&D activities. The Methylprednisolone Market scope for different regions will be provided in the final report.
  • Increasing prevalence of chronic diseases among a big quarter of the population, rising demand for topical corticosteroids, technological advancements in drug discovery process and rapid surge in investments for R&D activities and innovations in drugs by key market companies have helped in significant growth of Methylprednisolone Market.
  • Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Methylprednisolone Market report.
  • Stringent regulatory government policies for drug development is anticipated to hamper the market growth of the Methylprednisolone Industry.

Product - Segment Analysis
Infusion Type held the largest share in the product type segment of Methylprednisolone Market in 2019 and is estimated to grow at a CAGR of 3.78% during the forecast period 2020-2025. Methylprednisolone is part of a potent class of anti-inflammatory agents, known as corticosteroids. IV methylprednisolone is administered in a hospital or outpatient infusion center. Growing uses of ambulatory infusion pumps and increasing numbers of cases of chronic disorders have fuelled the growth of this segment. Oral Type held the second largest share in 2019, owing to formulation and repositioning of drugs using advanced oral delivery systems, and huge investments by key market players for in-house capabilities of development of oral drug delivery technologies. Infusion Type is estimated to be the fastest growing segment and is set to register the highest CAGR during the forecast period 2020-2025, owing to more investments in infusion devices for drugs by key market players and various advantages of Infusion Pump like accurate medications and technological innovations in healthcare sector.

Application Type - Segment Analysis
Medical Applications holds the major share in the application type segment of Methylprednisolone Market in 2019. Methylprednisolone is used to treat many different inflammatory conditions such as arthritis, lupus, psoriasis, ulcerative colitis, allergic disorders, gland (endocrine) disorders, and conditions that affect the skin, eyes, lungs, stomach, nervous system, or blood cells. Growing incidences of these disorders among a major section of the population and growing demand for efficient drug treatment have driven the market growth of this segment. Research & Development segment is forecast to grow at the fastest rate with the highest CAGR during the forecast period 2020-2025, owing to increasing investments by market players and demand for better advanced drugs for fighting the diseases. “The Perspectives of Immune Therapy in Coronavirus Disease 2019," were published in the Journal of Korean Medical Science, which demonstrated methylprednisolone effects in severe Covid-19 patients, showing the elevation of lymphocyte counts, a decrease of inflammatory markers, partial or complete resolution of specific lung affections, and negative nasal and oropharyngeal swab tests within a few days of therapy.

Geography - Segment Analysis
North America dominates the geography segment of Methylprednisolone Market with a share of more than 36.25% in 2019, followed by Europe. The well-developed economy of the region, rising health care expenditure, increasing incidence of chronic and other diseases and increasing investments by key market players for better R&D activities in this region have helped in the growth of Methylprednisolone Industry infrastructure. Europe held the second place in the geography segment share of the market, owing to presence of well-developed healthcare facilities, increasing prevalence of lifestyle related diseases and presence of key market players in this region.

However, Asia-Pacific is estimated to grow at a higher CAGR during the forecast period 2020-2025. This is owing to gradual growth of infusion pump market, increasing awareness about lifestyle diseases, and increasing disposable income of the population.

Drivers – Methylprednisolone Market
  • Increasing prevalence of lifestyle related diseases
Lifestyle diseases like hypertension, diabetes mellitus, dyslipidemia and overweight/obesity are the major risk factors for the development of cardiac disorders. With rapid economic development and increasing westernization of lifestyle in the past few decades prevalence of these diseases has reached alarming proportions among people in the recent years. More than 7 million people die of cancer each year and 30% of those diseases are attributed to lifestyle choices. Some of the most under-diagnosed conditions, chronic respiratory diseases (CRD) are a potent cause of death globally with 90% of the deaths taking place in low-income countries. This drives the demand for corticosteroids, primarily methylprednisolone in the drug market.
  • Technological advancements in drug discovery process
Technology has been a major driver of advances in drug discovery. Automation, nanofluidics, and assay technologies have played a major role in making the manufacturing and processing steps easier. For instance, Oakrum Pharma and Sungen Pharma have launched the genric version of Medrol after much demand for efficient and advanced acting drug. As a result, this is projected to drive the Infusion Market growth during the forecast period 2020-2025.

Challenges – Methylprednisolone Market
  • Stringent regulatory policies of government
Governments have the responsibility to protect their citizens in the areas where the citizens themselves are not able to do so. Thus, Governments need to establish strong policies to ensure that the manufacture, trade and use of drugs and medicines are regulated effectively. Given some minor side effects or interactions of methylprednisolone with action of other drugs, there are regulations on its prescription and dosage as well as manufacturing composition. This is anticipated to hamper the market growth during the forecast period 2020-2025.

Methylprednisolone Industry Outlook
Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Methylprednisolone Market. In 2019, Methylprednisolone Market share is consolidated by the top players present in the market. Methylprednisolone Market top 10 companies are Oakrum Pharma, Intelgenx Corp, Jubilant Cadista Pharmaceutical Inc, Pfizer Inc., Pharmacia, Sandoz, Teva Pharmaceutical, Tianjin Kingyork, Opko Health and Zhejiang Xianju Pharmaceutical Co.,Ltd. among others.

Acquisitions/Product Launches
  • In October 2019, Oakrum Pharma and SunGen Pharma announced the U.S. launch of generic version of Medrol (Methylprednisolone).
  • In March 2020, Pfizer Inc. announced that JADE COMPARE (B7451029) met its co-primary efficacy endpoints. Medicated topical therapy for corticosteroids were tested by participants with subcutaneous injections and therapies. The results hence found after trials were successful
  • In August 2016, OPKO Health completed acquisition of transition therapeutics. This would help it expand its global market of corticosteroids.
1. Methylprednisolone Market Overview
    1.1 Definitions and Scope
2. Methylprednisolone Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product Type
    2.3 Key trends by Application
    2.4 Key trends by Geography
3. Methylprednisolone Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Methylprednisolone Market - Startup Companies Scenario (Premium)
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Methylprednisolone Market – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Methylprednisolone Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Methylprednisolone Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Methylprednisolone Market – By Product Type (Market Size –$Million/$Billion)
    8.1 Infusion Type
    8.2 Oral Type
9. Methylprednisolone Market – By Application (Market Size –$Million/$Billion)
    9.1 Medical Applications
    9.2 Research & Development
10. Methylprednisolone Market – By Geography (Market Size –$Million/$Billion)
    10.1 North America
        10.1.1 U.S.
        10.1.2 Canada
        10.1.3 Mexico
    10.2 Europe
        10.2.1 U.K.
        10.2.2 Germany
        10.2.3 France
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Rest of Europe
    10.3 Asia-Pacific
        10.3.1 China
        10.3.2 India
        10.3.3 Japan
        10.3.4 South Korea
        10.3.5 Australia & New Zealand
        10.3.6 Rest of Asia-Pacific
    10.4 Rest of the World
        10.4.1 Middle East
        10.4.2 Africa
        10.4.3 South America
11. Methylprednisolone Market - Entropy
12. Methylprednisolone Market – Industry/Segment Competition Landscape   (Premium) 
    12.1 Market Share Analysis
        12.1.1 Global Market Share – Key Companies
        12.1.2 Market Share by Region – Key companies
        12.1.3 Market Share by Countries – Key Companies
        12.1.4 Best Practices for Companies
13. Methylprednisolone Market – Key Company List by Country Premium (Premium)
14. Methylprednisolone Market Company Analysis
    14.1 Company 1
    14.2 Company 2
    14.3 Company 3
    14.4 Company 4
    14.5 Company 5
    14.6 Company 6
    14.7 Company 7
    14.8 Company 8
    14.9 Company 9
    14.10 Company 10 and more
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Global Methylprednisolone Market, By Product Type Market 2019-2024 ($M)
1.1 Infusion Type Market 2019-2024 ($M) - Global Industry Research
1.1.1 Sublingual Film Market 2019-2024 ($M)
1.1.2 Fully Dissolving Dental/Buccal Film Market 2019-2024 ($M)
1.2 Oral Type Market 2019-2024 ($M) - Global Industry Research
2.Global Global Methylprednisolone Market, By Product Type Market 2019-2024 (Volume/Units)
2.1 Infusion Type Market 2019-2024 (Volume/Units) - Global Industry Research
2.1.1 Sublingual Film Market 2019-2024 (Volume/Units)
2.1.2 Fully Dissolving Dental/Buccal Film Market 2019-2024 (Volume/Units)
2.2 Oral Type Market 2019-2024 (Volume/Units) - Global Industry Research
3.North America Global Methylprednisolone Market, By Product Type Market 2019-2024 ($M)
3.1 Infusion Type Market 2019-2024 ($M) - Regional Industry Research
3.1.1 Sublingual Film Market 2019-2024 ($M)
3.1.2 Fully Dissolving Dental/Buccal Film Market 2019-2024 ($M)
3.2 Oral Type Market 2019-2024 ($M) - Regional Industry Research
4.South America Global Methylprednisolone Market, By Product Type Market 2019-2024 ($M)
4.1 Infusion Type Market 2019-2024 ($M) - Regional Industry Research
4.1.1 Sublingual Film Market 2019-2024 ($M)
4.1.2 Fully Dissolving Dental/Buccal Film Market 2019-2024 ($M)
4.2 Oral Type Market 2019-2024 ($M) - Regional Industry Research
5.Europe Global Methylprednisolone Market, By Product Type Market 2019-2024 ($M)
5.1 Infusion Type Market 2019-2024 ($M) - Regional Industry Research
5.1.1 Sublingual Film Market 2019-2024 ($M)
5.1.2 Fully Dissolving Dental/Buccal Film Market 2019-2024 ($M)
5.2 Oral Type Market 2019-2024 ($M) - Regional Industry Research
6.APAC Global Methylprednisolone Market, By Product Type Market 2019-2024 ($M)
6.1 Infusion Type Market 2019-2024 ($M) - Regional Industry Research
6.1.1 Sublingual Film Market 2019-2024 ($M)
6.1.2 Fully Dissolving Dental/Buccal Film Market 2019-2024 ($M)
6.2 Oral Type Market 2019-2024 ($M) - Regional Industry Research
7.MENA Global Methylprednisolone Market, By Product Type Market 2019-2024 ($M)
7.1 Infusion Type Market 2019-2024 ($M) - Regional Industry Research
7.1.1 Sublingual Film Market 2019-2024 ($M)
7.1.2 Fully Dissolving Dental/Buccal Film Market 2019-2024 ($M)
7.2 Oral Type Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Methylprednisolone Market Revenue, 2019-2024 ($M)
2.Canada Methylprednisolone Market Revenue, 2019-2024 ($M)
3.Mexico Methylprednisolone Market Revenue, 2019-2024 ($M)
4.Brazil Methylprednisolone Market Revenue, 2019-2024 ($M)
5.Argentina Methylprednisolone Market Revenue, 2019-2024 ($M)
6.Peru Methylprednisolone Market Revenue, 2019-2024 ($M)
7.Colombia Methylprednisolone Market Revenue, 2019-2024 ($M)
8.Chile Methylprednisolone Market Revenue, 2019-2024 ($M)
9.Rest of South America Methylprednisolone Market Revenue, 2019-2024 ($M)
10.UK Methylprednisolone Market Revenue, 2019-2024 ($M)
11.Germany Methylprednisolone Market Revenue, 2019-2024 ($M)
12.France Methylprednisolone Market Revenue, 2019-2024 ($M)
13.Italy Methylprednisolone Market Revenue, 2019-2024 ($M)
14.Spain Methylprednisolone Market Revenue, 2019-2024 ($M)
15.Rest of Europe Methylprednisolone Market Revenue, 2019-2024 ($M)
16.China Methylprednisolone Market Revenue, 2019-2024 ($M)
17.India Methylprednisolone Market Revenue, 2019-2024 ($M)
18.Japan Methylprednisolone Market Revenue, 2019-2024 ($M)
19.South Korea Methylprednisolone Market Revenue, 2019-2024 ($M)
20.South Africa Methylprednisolone Market Revenue, 2019-2024 ($M)
21.North America Methylprednisolone By Application
22.South America Methylprednisolone By Application
23.Europe Methylprednisolone By Application
24.APAC Methylprednisolone By Application
25.MENA Methylprednisolone By Application
26.Endo International Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Sandoz, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Jubilant Cadista Pharmaceutical Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Teva Pharmaceutical, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Transition Therapeutics, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Xianju, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Pfizer Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Pharmacia, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Intelgenx Corp, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Tianjin Kingyork, Sales /Revenue, 2015-2018 ($Mn/$Bn)